Pharma Event Intelligence Platform
Track global conferences, regulatory summits, and clinical congresses with coverage, company intelligence, and networking signals.
All Events
10 live · 11 in 14 days · 23 abstracts indexed · 8 therapeutic areas tracked
What's moving in Global
10 congresses live in Global
Active now: APPOS Hartford. NovaPharmaNews is tracking presentations and company signals in real time.
11 events in the next 14 days
A dense catalyst window for FDA · EMA · NMPA-market BD, investor positioning, and clinical data anticipation.
19 tier-1 conferences through 60 days
Major congresses drive pipeline narratives, licensing windows, and sell-side estimate revisions across Global Pharmaceutical Markets.
General leads the Global calendar
11 upcoming events cluster in general — the highest sector density in the next 60 days.
1 regulatory summit on deck
FDA · EMA · NMPA policy, compliance, and submission strategy forums for regulatory affairs and market access teams.
23 presentations indexed
17 companies mapped across upcoming Global congresses — pipeline and investor-impact scoring applied.
Global pharma outlook — next 60 days
Q2–Q3 2026 is a dense catalyst window across FDA, EMA, and NMPA corridors. 10 congresses are live now (APPOS Hartford), with 19 tier-1 meetings and 11 events in the next 14 days shaping investor positioning and BD outreach.
Conviction watchlist: BIO, DIA, APPOS Hartford, IMPHARMA2026. These forums historically drive registrational readout narratives, licensing windows, and regulatory policy debates that ripple across 12–18 month pipeline valuations.
NovaPharmaNews has indexed 23 presentations across 17 companies — linking congress data to editorial coverage, not republishing organizer agendas.
10 active congresses — highest urgency for data readouts and same-day market signals.
11 near-term meetings — BD travel and investor preview cycle.
1 regulatory forums — submission strategy and compliance benchmarks.
general leads with 11 upcoming events.
Why global pharma events matter now
Pharmaceutical congresses are catalyst clusters — not calendar entries. Across US, EU, and APAC, 19 tier-1 conferences and 11 near-term meetings converge clinical data, regulatory posture, and partnership timing in the next 60 days.
The highest-conviction global watchlist centers on BIO, DIA, APPOS Hartford. These congresses reset consensus estimates, trigger licensing conversations, and surface competitive readouts.
261+ published articles are linked to this calendar — combining presentation intelligence, company mapping, and editorial analysis.
Prioritize 10 live + 19 tier-1 congresses where guidance and readouts reset models.
17 companies indexed — use partnering calendars for licensing and co-development windows.
1 regulatory forums plus clinical data calendar for trial-design and submission benchmarks.
How to read this page
Two sections serve different intelligence needs. Live Events are active congresses; Major Conferences are editor-selected tier-1 planning priorities on the FDA · EMA · NMPA calendar.
Live Events
Congress in session right now across Global. These are active catalyst windows — not upcoming listings.
- Real-time presentation and company signals as sessions run
- Breaking coverage and data-readout alerts where editorial is filed
- Highest urgency for investors monitoring same-day market moves
Major Conferences
Editorially curated tier-1 congresses on the FDA · EMA · NMPA calendar — selected for market-moving history, attendance scale, and pipeline density.
- Tier-1 global or major designation — not every regional meeting
- Pre-event briefs, key-data previews, and investor-impact scoring
- Planning horizon: BD outreach, travel, and competitive intelligence prep
Most important events — next 60 days
- 1 BIO Jun 22 – 25, 2026
Biocom is excited to announce the upcoming Noven Pharmaceuticals Partner Day on Wednesday, June 10.
- 2 DIA Jun 14 – 18, 2026
Staple biopharma event centered around best practices, regulatory trends, operational excellence, and global compliance frameworks across regulatory, clinical, …
- 3 APPOS Hartford Live now
APPOS Hartford is a dedicated oncology summit for advanced practice providers (NPs, PAs, pharmacists, RNs), a rapidly growing segment of the oncology workforce …
- 4 IMPHARMA2026 Jun 15 – 17, 2026
Global Medical Health & Pharmaceutical Industry Conference 2026 brings together doctors, scientists, pharma experts, and healthcare leaders to explore medical i…
- 5 RESI San Diego Jun 22 – 23, 2026
RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three days of virtual partn…
- 6 Drug Discovery USA Jun 16 – 17, 2026
Drug Discovery USA 2026 marks ELRIG's first US edition, hosted at Pfizer's Cambridge campus, signaling strong transatlantic collaboration in addressing intracta…
- 7 HLTH Europe 2026 Jun 16 – 17, 2026
Europe’s largest annual congress in haematopoietic cell transplantation (HCT) and cellular therapy.
- 8 LogiPharma Asia Jun 16 – 17, 2026
LogiPharma Asia 2026 is the region's premier pharma supply chain summit, convening 100+ senior executives at a time when APAC regulatory divergence (e.g., China…
Companies most active across events
Sponsors and presenters with the broadest congress footprint in Global over the next 60 days.
- 1
Presenting at 3 congresses — broad Q2 visibility across BIO, Drug Discovery USA, IMPHARMA2026.
BIO · Drug Discovery USA · IMPHARMA2026
- 2
- 3
- 4
- 5
Single high-signal presentation at IMPHARMA2026 with elevated investor-impact score.
IMPHARMA2026
- 6
Single high-signal presentation at BIO with elevated investor-impact score.
BIO
- 7
Single high-signal presentation at IMPHARMA2026 with elevated investor-impact score.
IMPHARMA2026
- 8
Single high-signal presentation at RESI San Diego with elevated investor-impact score.
RESI San Diego
Drug pipelines to watch
INN-level readouts indexed from upcoming congress abstracts — ranked by investor-impact score.
- 1pelacarsenNovartisImpact 5/5
On the BIO, Drug Discovery USA agenda (Phase Iii) in Cardiovascular disease (elevated Lp(a)) — high investor-impact readout.
Phase Iii · Cardiovascular disease (elevated Lp(a)) · cardiovascular disease (elevated lipoprotein(a))
- 2
On the DIA agenda (Phase Iii) in 1L hepatocellular carcinoma — high investor-impact readout.
Phase Iii · 1L hepatocellular carcinoma
- 3
On the DIA agenda (Phase Iii) in relapsed/refractory diffuse large B-cell lymphoma — high investor-impact readout.
Phase Iii · relapsed/refractory diffuse large B-cell lymphoma
- 4
On the IMPHARMA2026 agenda (Phase Iii) in Migraine prevention — high investor-impact readout.
Phase Iii · Migraine prevention
- 5VRDN-008Viridian Therapeutics
On the Drug Discovery USA agenda (Phase I) in Healthy volunteers (Phase 1).
Phase I · Healthy volunteers (Phase 1)
- 6nivolumab(Opdivo, Yervoy)Bristol-Myers Squibb
On the ESMO Gastrointestinal Cancers Congress agenda in unresectable hepatocellular carcinoma (first-line).
unresectable hepatocellular carcinoma (first-line)
- 7rese-celCabaletta Bio
On the RESI San Diego agenda (Phase I) in Dermatomyositis.
Phase I · Dermatomyositis
Therapeutic area intelligence
Where congress density, tier-1 flagships, and presentation coverage cluster in Global.
BIO · BIO Asia-Taiwan 2026 · RESI San Diego
3 upcoming biotech events (3 tier-1) — flagship: BIO, BIO Asia-Taiwan 2026, RESI San Diego. 11 presentations indexed. Biotech forums concentrate partnering, financing, and early-stage pipeline narratives ahead of IND and Phase I milestones.
2026 TPA Conference · APPOS Austin · APPOS Hartford · Cardinal Health RBC
11 upcoming general events (11 tier-1) — flagship: 2026 TPA Conference, APPOS Austin, APPOS Hartford, Cardinal Health RBC. 8 presentations indexed. Cross-therapeutic congresses attract diversified BD pipelines — useful for platform deals and multi-indication licensing.
DIA
1 upcoming regulatory events (1 tier-1) — flagship: DIA. 3 presentations indexed. Regulatory summits set submission strategy, inspection readiness, and agency interaction benchmarks for the next review cycle.
AACR/ASCO Methods in Clinical · ESMO Gastrointestinal Cancers Congress
2 upcoming oncology events (2 tier-1) — flagship: AACR/ASCO Methods in Clinical, ESMO Gastrointestinal Cancers Congress. 1 presentations indexed. Oncology congresses drive the highest density of registrational readouts and label-expansion catalysts — priority for investors and clinical teams.
LogiPharma Asia · LogiPharma Asia 2026
2 upcoming manufacturing events (2 tier-1) — flagship: LogiPharma Asia, LogiPharma Asia 2026. Manufacturing and CMC events signal supply-chain, biosimilar, and tech-transfer priorities for operations leaders.
Desk notes on upcoming congresses
Investor, regulatory, and competitive implications distilled from event intelligence — not organizer marketing copy.
Biocom is excited to announce the upcoming Noven Pharmaceuticals Partner Day on Wednesday, June 10.
FDA and CMS policy discussions around evidence generation, 340B, and real-world data often surface at biotech leadership forums.
Competitive positioning among top biotech players and adjacent technology vendors is a core theme — compare outcomes with prior editions and peer conferences.
Expect signals on pricing, formulary strategy, and partnership economics relevant to biotech markets in the US region.
Biocom is excited to announce the upcoming Noven Pharmaceuticals Partner Day on Wednesday, June 10.
Biocom is excited to announce the upcoming Noven Pharmaceuticals Partner Day on Wednesday, June 10.
Congress intelligence by desk
Clinical readouts, FDA · EMA · NMPA forums, partnering windows, and market-moving congresses — curated for Global, not a raw directory export.
Clinical data calendar
Indexed abstracts, trial phases, and NCT-linked readouts across upcoming congresses.
- pelacarsenlate-breakerPhase IiiImpact 5Phase III Lp(a)HORIZON Study of Pelacarsen: Readout Results
- pelacarsenlate-breakerPhase IiiImpact 5Phase 3 Lp(a)HORIZON study results for pelacarsen
- pelacarsenlate-breakerPhase IiiImpact 5Phase III Lp(a)HORIZON study of pelacarsen: top-line results
- glofitamab(Columvi)oralPhase IiiImpact 5STARGLO: Phase 3 trial comparing glofitamab plus gemcitabine and oxaliplatin with rituximab plus gemcitabine
- oralPhase IiiImpact 4Top-line Data Readout of the Twin Phase 3 ENSURE Trials
- oralPhase IiiImpact 4Phase III data readouts for key studies in oncology (H1 and H2 2026)
- oralPhase Ii1-Year Data from the REVEAL-1 Cohort of Revita
Regulatory events calendar
FDA · EMA · NMPA summits, DIA forums, and compliance congresses for regulatory affairs teams.
- DIAJun 14 – Jun 18, 2026Philadelphia
In 2 days — FDA · EMA · NMPA policy, submission strategy, and compliance forum (tier-1). 4 linked coverage articles.
Partnership & licensing events
BIO, partnering summits, and BD forums where deal flow concentrates.
- BIOJun 22 – Jun 25, 2026Tier 1
Flagship BD partnering forum — licensing, co-development, and platform deal-making at global scale.
- BIO Asia-Taiwan 2026Jul 15 – Jul 19, 2026Tier 1
Flagship BD partnering forum — licensing, co-development, and platform deal-making at global scale.
Market-moving conferences
Ranked by editorial coverage, abstract density, and tier-1 designation — investor desk priority.
- 1BIO136Jun 22 – Jun 25, 2026
Market-moving score 136 (tier-1 · 3 articles · 5 abstracts indexed) — historically drives estimate revisions and sector rotation.
- 2DIA116Jun 14 – Jun 18, 2026
Market-moving score 116 (tier-1 · 4 articles · 3 abstracts indexed) — historically drives estimate revisions and sector rotation.
- 3Jun 15 – Jun 17, 2026
Market-moving score 97 (tier-1 · 1 articles · 4 abstracts indexed) — historically drives estimate revisions and sector rotation.
- 4Jun 22 – Jun 23, 2026
Market-moving score 96 (tier-1 · 1 articles · 6 abstracts indexed) — historically drives estimate revisions and sector rotation.
- 5Jun 16 – Jun 17, 2026
Market-moving score 94 (tier-1 · 1 articles · 2 abstracts indexed) — historically drives estimate revisions and sector rotation.
- 6Jun 16 – Jun 17, 2026
Market-moving score 93 (tier-1 · 1 articles · 1 abstracts indexed) — historically drives estimate revisions and sector rotation.
Build your event watchlist
Follow congresses, companies, pipeline programs, or therapeutic areas. Weekly digest + catalyst alerts — no account required.
LIVE NOW Happening Right Now
Active catalyst window — real-time readouts and coverage where indexed.
Market-moving conferences
Impact-ranked · editorial priorityBIO
San Diego, USA • Jun 22 – Jun 25, 2026
Biocom is excited to announce the upcoming Noven Pharmaceuticals Partner Day on Wednesday, June 10.
DIA
Philadelphia, USA • Jun 14 – Jun 18, 2026
Staple biopharma event centered around best practices, regulatory trends, operational excellence, and global compliance frameworks across re…
APPOS Hartford
Hartford, Connecticut • Jun 12 – Jun 13, 2026
APPOS Hartford is a dedicated oncology summit for advanced practice providers (NPs, PAs, pharmacists, RNs), a rapidly growing segment of the…
IMPHARMA2026
Copenhagen, Denmark • Jun 15 – Jun 17, 2026
Global Medical Health & Pharmaceutical Industry Conference 2026 brings together doctors, scientists, pharma experts, and healthcare leaders …
RESI San Diego
San Diego, USA • Jun 22 – Jun 23, 2026
RESI Boston 2026, a key component of Biotech Week Boston, will take place on September 22-23 at the Westin Copley Place, followed by three d…
Drug Discovery USA
Cambridge, USA • Jun 16 – Jun 17, 2026
Drug Discovery USA 2026 marks ELRIG's first US edition, hosted at Pfizer's Cambridge campus, signaling strong transatlantic collaboration in…
Recently Concluded
Coverage archives availableJune 2026
17th Annual Clinical
Mumbai, India • Jun 10 – Jun 11, 2026
This summit is the key APAC barometer for the accelerating shift of clinical trial operations to India, driven by regulatory streamlining an…
ESMO Preceptorship on Neuroendocrine
Hong Kong SAR, China • Jun 10 – Jun 11, 2026
This ESMO Preceptorship on NENs is a premier educational event in APAC, updating clinicians on diagnostic and therapeutic strategies for neu…
ASCO 2026
Chicago, United States • Jun 5 – Jun 9, 2026
The 2026 ASCO Annual Meeting is The Place to Be.
EULAR 2026
London, UK • Jun 3 – Jun 6, 2026
The EULAR 2026 Congress will take place at the Excel London from Wednesday, 3 June to Saturday, 6 June 2026.
THMA Pharmacy Growth
Carlsbad, USA • Jun 3 – Jun 5, 2026
The Health Management Academy's (THMA) Pharmacy Growth Collaborative brings health system pharmacy leaders and select industry executives .…
CPhI
Philadelphia, USA • Jun 3 – Jun 4, 2026
Breaking Barriers: Women's Networking .
May 2026
ASCO
Chicago, USA • May 29 – Jun 2, 2026
The 2026 ASCO Annual Meeting is The Place to Be.
Global Clinical Trials
London, United Kingdom • May 27 – May 28, 2026
Premier platform uniting global leaders, clinical researchers, regulatory experts, and technology pioneers to foster collaboration, drive in…
The Pharma Sustainability
Geneva, Switzerland • May 27 – May 28, 2026
Europe’s largest annual congress in haematopoietic cell transplantation (HCT) and cellular therapy.
Pharma Partnering EU
Basel, Switzerland • May 20 – May 21, 2026
Biocom is excited to announce the upcoming Noven Pharmaceuticals Partner Day on Wednesday, June 10.
Navigating the Data
Boston, USA • May 20 – May 21, 2026
The 2026 Federal Statistical Research Data Center (FSRDC) Annual Research Conference will be taking place on Friday, September 18, 2026, at …
SLAS Europe 2026
Vienna, Austria • May 20 – May 21, 2026
Laboratory and screening conference addressing drug discovery technologies, automation, and diagnostic innovations.
Clinical Research Patient
TBD, USA • May 19 – May 20, 2026
Join us at the 28th Precision in Clinical Trials Summit Boston (PCT) for a two-day journey into the insightful world of clinical trials.…
Regulatory Education for
Not specified • May 19 – May 20, 2026
Conference on Innovative Regulatory Strategies to Advance Medical Products, covering topics like Advanced Drug Manufacturing, AI in Drug Dev…
ReDI 2026 Conference
Not specified • May 19 – May 20, 2026
The 2026 Federal Statistical Research Data Center (FSRDC) Annual Research Conference will be taking place on Friday, September 18, 2026, at …
Pharmaceutical Events Coverage
NovaPharma News covers the most important pharmaceutical conferences and medical congresses globally. Our editorial team provides US-focused event coverage, European regulatory meetings, and Asia-Pacific pharma congresses—delivering preview analysis, live data coverage, and post-event recap articles.
Each event hub includes key data presentations, company analyses, and drug pipeline spotlights. Our investor-focused coverage helps you stay informed on the conferences that move pharma markets.